The OncoSim-Breast cancer microsimulation model
Preprint
Abstract
Background: The increasing demand for health care resources requires measures to evaluate the impact of cancer control approaches. A cancer simulation model can help integrate new knowledge to inform clinical and policy decisions. OncoSim-Breast is a breast cancer simulation model. This paper aims to describe the key assumptions in the OncoSim-Breast model and how well it reproduces more recent breast cancer trends and the observed effects in a randomized screening trial. Methods: The OncoSim-Breast model simulates the onset, growth and spread of invasive and ductal carcinoma in situ tumours. The model combines Canadian cancer incidence, mortality, screening program and cost data to project population-level outcomes. Users can change the model input to answer specific policy questions. Here we report three validation exercises. First, we compared the model’s projected breast cancer incidence and stage distributions with the observed data in the Canadian Cancer Registry. Second, we compared OncoSim’s projected breast cancer mortality with the Vital Statistics. Third, we replicated the UK Age trial to compare the model’s projections with the trial’s observed screening effects. Results: OncoSim-Breast’s projected incidence, mortality and stage distribution of breast cancer were close to the observed data in the Canadian Cancer Registry and the Vital Statistics. OncoSim-Breast also reproduced the breast cancer screening effects observed in the UK Age trial. Interpretation: OncoSim-Breast’s ability to reproduce the observed population-level breast cancer trends and the screening effects in a randomized trial increases the confidence of using its results to inform policy decisions related to early detection of breast cancer.Keywords
All Related Versions
- Published version: Current Oncology, 29 (3), 1619.
This publication has 27 references indexed in Scilit:
- Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer ModelsMedical Decision Making, 2018
- Simulating results from trials of sigmoidoscopy screening using the OncoSim microsimulation modelJournal of Cancer Policy, 2018
- OA 06.01 Costs and Cost-Effectiveness of Smoking Cessation Within an Organized CT Lung Cancer (LC) Screening ProgramJournal of Thoracic Oncology, 2017
- Projected effect of fecal immunochemical test threshold for colorectal cancer screening on outcomes and costs for Canada using the OncoSim microsimulation modelJournal of Cancer Policy, 2017
- OA17.02 Potential Health and Economic Consequences of Organized vs Opportunistic Lung Cancer Screening in CanadaJournal of Thoracic Oncology, 2017
- Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and GöteborgJournal of Medical Screening, 2016
- Implementing Low-Dose Computed Tomography Screening for Lung Cancer in Canada: Implications of Alternative At-Risk Populations, Screening Frequency, and DurationCurrent Oncology, 2016
- Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patientsBMJ, 2015
- Using the Cancer Risk Management Model to Evaluate Colorectal Cancer Screening Options for CanadaCurrent Oncology, 2015
- The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 YearsAnnals of Internal Medicine, 2002